The Pholcodine case. cough medicines, ige-sensitization, and anaphylaxis: A devious connection

World Allergy Organization Journal

Volumn 5, Issue 7, 2012, Pages 73-78

  Florvaag, E ^a,b   Johansson, S G O ^c,d  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaphylaxis; IgE antibodies; Over the counter cough medicines; Pholcodine

Indexed keywords

ALLERGEN; ANTITUSSIVE AGENT; ATRACURIUM; CODEINE; EPITOPE; GUAIFENESIN; IMMUNOGLOBULIN E; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NOSCAPINE; PHOLCODINE; QUATERNARY AMMONIUM DERIVATIVE; ROCURONIUM; SUXAMETHONIUM;

AFRICA; ANAPHYLAXIS; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ASIA; BINDING SITE; CORRELATION ANALYSIS; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SENSITIZATION; DRUG USE; EFFECTOR CELL; EUROPE; HEALTH HAZARD; HUMAN; IMMUNOGENICITY; MORTALITY; NETHERLANDS; NORWAY; PACIFIC ISLANDS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCANDINAVIA; STRUCTURE ACTIVITY RELATION; SWEDEN; UNITED STATES;

EID: 84866066407     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e318261eccc     Document Type: Review

References (25)

1. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2008;(1):CD001831.
2. Available at: http://www.ema.europa.eu/ema/index.jsp?curlpages/news- and-events/news/2011/11/news-detail-001389.jsp&midWC0b01ac0580 04d5c1. Accessed June 20, 2012.
3. Chen ZR, Bochner F, Somogyi A. Pharmacokinetics of pholcodine in healthy volunteers: Single and chronic dosing studies. Br J Clin Pharmacol. 1988;26:445-453.
4. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature. 1983;306:262-264. (Pubitemid 14232353)
5. Florvaag E, Johansson SGO, Öman H, Venemalm L, Degerbeck F, Dybendal T, Lundberg M. Prevalence of IgE antibodies to morphine. Relation to the high and low incidence of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand. 2005;49:437-444. (Pubitemid 40488565)
6. Florvaag E, Johansson SGO, Irgens Å, de Pater GH. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy. 2011;66:955-960.
7. Johansson SGO, Öman H, Nopp A, Florvaag E. Pholcodine caused anaphylaxis in Sweden 30-years ago. Allergy. 2009;64:820-821.
8. Johansson SGO, Florvaag E, Oman H, Poulsen LK, Mertes PM, et al. National pholcodine consumption and prevalence of IgE-sensitization; a multicentre study. Allergy. 2010;65:498-502.
9. Florvaag E, Johansson SGO, Öman H, Harboe T, Nopp A. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study. Allergy. 2006;61:49-55. (Pubitemid 43381191)
10. Dewachter P, Mouton-Faivre C, Castells MC, Hepner DL. Anesthesia in the patient with multiple drug allergies: Are all allergies the same? Current Opin Anaesthesiol. 2011;24:320-325.
11. Harboe T, Johansson SGO, Florvaag E, Öman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy. 2007;62:1445-1450. (Pubitemid 350045601)
12. Johansson SGO, Nopp A, van Hage M, Olofsson N, Lundahl J, et al. Passive IgE-sensitization by blood transfusion. Allergy. 2005;60:1192- 1199. (Pubitemid 41153149)
13. Ringdén O, Persson U, Johansson SGO. Are increased IgE-levels a signal of an acute graft-versus-host reaction? Immunol Rev. 1983;71:57-75. (Pubitemid 13007964)
14. Fisher MM, Baldo BA. Immunoassays for the diagnosis of anaphylaxis to neuromuscular blocking drugs: The value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care. 2000;28:167-170. (Pubitemid 30201232)
15. Laroche D, Chollet-Martin S, Léturgie P, Malzac L, Vergnaud MC, et al. Evaluation of a new routine diagnostic test for immunoglobulin E sensitization to neuromuscular blocking agents. Anesthesiology. 2011;114:91-97.
16. Harboe T, Guttormsen AB, Irgens Å, Dybendal T, Florvaag E. Anaphylaxis during anaesthesia in Norway. A six-year single centre study. Anesthesiology. 2005;102:897-903.
17. Johansson SGO, Nopp A, Öman H, Stahl-Skov P, Hunting AS, Guttormsen AB. Anaphylaxis to Patent Blue V. II. A unique IgE-mediated reaction. Allergy. 2010;66 :124-129.
18. Mertes P-M, Laxenaire MC. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep. 2004;4:7-17.
19. Guttormsen AB, Harboe T, Florvaag E. Allergic reactions during anesthesiada national network for registration, diagnosis and followup. Tidsskr Nor Laegeforen. 2000;120:127.
20. Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011;21:442-453.
21. Krøigaard M, Garvey LH, Menne T, Husum B. Allergic reactions in anaesthesia: Are suspected causes confirmed on subsequent testing? Br J Anaesth. 2005;95:468-471. (Pubitemid 41418740)
22. Harper NJN, Dixon T, Dugué P, et al. Guidelines. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia. 2009;64: 199-211.
23. Currie M, Webb RK, Williamson JA, Russel WJ, Mackay P. The Australian Incident Monitoring Study. Clinical anaphylaxis: An analysis of 2000 incident reports. Anaesth Intensive Care. 1993;21:621-625. (Pubitemid 23311294)
24. Johansson SGO, Öman H, Degerbeck F, Tunelli J, Florvaag E, Nopp A. Anaphylaxis to atracuriumda non-QAI-dependent reaction? Acta Anaesth Scand. 2012;56:262-263.
25. Florvaag E, Johansson SGO. Pholcodine in cough medicines and IgEsensitization in the EU: An urgent task. Allergy. 2012;67:581-582.